A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 47/48 (2006.01) C07K 14/01 (2006.01) C07K 14/50 (2006.01) C12N 7/00 (2006.01) C12N 15/70 (2006.01) C12N 15/87 (2006.01)
Patent
CA 2302293
Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
Des virus bactériens filamenteux présentant un ligand sur leur surface sont utilisés pour administrer un gène thérapeutique à une cellule. Le ligand est une protéine de fusion comportant une protéine de capside de phage conjuguée de façon covalente à des virus bactériens, ou formant un complexe avec des virus bactériens modifiés.
Baird Andrew
Johnson Wendy
Larocca David
Gowling Lafleur Henderson Llp
Selective Genetics Inc.
LandOfFree
Receptor-mediated gene delivery using bacteriophage vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor-mediated gene delivery using bacteriophage vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor-mediated gene delivery using bacteriophage vectors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1701563